Rank | Gene Set | Z-score |
---|---|---|
1 | cellular extravasation (GO:0045123) | 8.06853987 |
2 | production of molecular mediator involved in inflammatory response (GO:0002532) | 7.06639492 |
3 | neutrophil mediated immunity (GO:0002446) | 6.70361590 |
4 | leukocyte aggregation (GO:0070486) | 6.46977151 |
5 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.40464457 |
6 | defense response to fungus (GO:0050832) | 6.37890020 |
7 | neutrophil activation involved in immune response (GO:0002283) | 6.15248815 |
8 | macrophage differentiation (GO:0030225) | 5.78379512 |
9 | detection of bacterium (GO:0016045) | 5.77210989 |
10 | detection of other organism (GO:0098543) | 5.69661718 |
11 | lymphangiogenesis (GO:0001946) | 5.65486248 |
12 | response to fungus (GO:0009620) | 5.54590860 |
13 | positive regulation of mast cell activation (GO:0033005) | 5.54009743 |
14 | respiratory burst (GO:0045730) | 5.38733508 |
15 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.18141891 |
16 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.18141891 |
17 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.13674204 |
18 | myeloid leukocyte mediated immunity (GO:0002444) | 5.12511009 |
19 | neutrophil activation (GO:0042119) | 5.01884841 |
20 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.88974722 |
21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.83841727 |
22 | sequestering of metal ion (GO:0051238) | 4.81106403 |
23 | neutrophil chemotaxis (GO:0030593) | 4.71800217 |
24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.70840192 |
25 | wound healing, spreading of epidermal cells (GO:0035313) | 4.66260921 |
26 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.65816771 |
27 | neutrophil migration (GO:1990266) | 4.58950687 |
28 | granulocyte activation (GO:0036230) | 4.57247711 |
29 | regulation of mast cell activation (GO:0033003) | 4.56910703 |
30 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.47993833 |
31 | negative regulation of phagocytosis (GO:0050765) | 4.45162269 |
32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.41589008 |
33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.34434643 |
34 | detection of molecule of bacterial origin (GO:0032490) | 4.33994957 |
35 | negative regulation of focal adhesion assembly (GO:0051895) | 4.33896409 |
36 | negative regulation of cell junction assembly (GO:1901889) | 4.33896409 |
37 | negative regulation of adherens junction organization (GO:1903392) | 4.33896409 |
38 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.21613551 |
39 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.15490465 |
40 | regulation of endothelial cell differentiation (GO:0045601) | 4.12964694 |
41 | response to peptidoglycan (GO:0032494) | 4.12625248 |
42 | regulation of leukocyte degranulation (GO:0043300) | 4.11430168 |
43 | negative regulation of endothelial cell migration (GO:0010596) | 4.08389048 |
44 | endodermal cell differentiation (GO:0035987) | 4.08006580 |
45 | regulation of mast cell degranulation (GO:0043304) | 4.07828471 |
46 | granulocyte chemotaxis (GO:0071621) | 4.02511293 |
47 | regulation of receptor binding (GO:1900120) | 4.01288850 |
48 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.00690228 |
49 | granulocyte migration (GO:0097530) | 3.91434043 |
50 | lipoxygenase pathway (GO:0019372) | 3.90129572 |
51 | leukotriene biosynthetic process (GO:0019370) | 3.88802736 |
52 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.85901973 |
53 | positive regulation of mast cell degranulation (GO:0043306) | 3.85901973 |
54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.83719617 |
55 | disruption of cells of other organism (GO:0044364) | 3.81884436 |
56 | killing of cells of other organism (GO:0031640) | 3.81884436 |
57 | chondrocyte proliferation (GO:0035988) | 3.75212957 |
58 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.73317397 |
59 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.73317397 |
60 | endocrine process (GO:0050886) | 3.73317397 |
61 | negative regulation of mast cell activation (GO:0033004) | 3.70196244 |
62 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.69519706 |
63 | regulation of regulated secretory pathway (GO:1903305) | 3.68849830 |
64 | macrophage activation (GO:0042116) | 3.68183057 |
65 | positive regulation of urine volume (GO:0035810) | 3.63349612 |
66 | angiogenesis involved in wound healing (GO:0060055) | 3.61094128 |
67 | artery development (GO:0060840) | 3.59237352 |
68 | leukotriene metabolic process (GO:0006691) | 3.58448192 |
69 | response to host immune response (GO:0052572) | 3.55995699 |
70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.55995699 |
71 | positive regulation of lamellipodium assembly (GO:0010592) | 3.55797847 |
72 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.55078909 |
73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.54606629 |
74 | response to host (GO:0075136) | 3.54606629 |
75 | response to host defenses (GO:0052200) | 3.54606629 |
76 | dendritic cell chemotaxis (GO:0002407) | 3.50326917 |
77 | pentose-phosphate shunt (GO:0006098) | 3.49964226 |
78 | macrophage activation involved in immune response (GO:0002281) | 3.41029581 |
79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.38000176 |
80 | leukocyte degranulation (GO:0043299) | 3.37740525 |
81 | dendritic cell migration (GO:0036336) | 3.36796790 |
82 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.36786655 |
83 | superoxide anion generation (GO:0042554) | 3.35725155 |
84 | endothelial cell differentiation (GO:0045446) | 3.35670211 |
85 | positive regulation of receptor recycling (GO:0001921) | 3.33607764 |
86 | endothelial tube morphogenesis (GO:0061154) | 3.31033368 |
87 | morphogenesis of an endothelium (GO:0003159) | 3.31033368 |
88 | immunoglobulin mediated immune response (GO:0016064) | 3.29174003 |
89 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.29146016 |
90 | regulation of interleukin-8 secretion (GO:2000482) | 3.28321633 |
91 | positive regulation of macrophage activation (GO:0043032) | 3.27424286 |
92 | detection of external biotic stimulus (GO:0098581) | 3.26589643 |
93 | lymph vessel development (GO:0001945) | 3.26178917 |
94 | leukocyte cell-cell adhesion (GO:0007159) | 3.25846511 |
95 | regulation of natural killer cell differentiation (GO:0032823) | 3.23020651 |
96 | defense response to Gram-positive bacterium (GO:0050830) | 3.21424745 |
97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.20649320 |
98 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.19784392 |
99 | leukocyte mediated cytotoxicity (GO:0001909) | 3.17849407 |
100 | endothelium development (GO:0003158) | 3.16537378 |
101 | negative regulation of interleukin-12 production (GO:0032695) | 3.15876319 |
102 | sprouting angiogenesis (GO:0002040) | 3.15602630 |
103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14763586 |
104 | NADPH regeneration (GO:0006740) | 3.12037198 |
105 | positive regulation of vesicle fusion (GO:0031340) | 3.09649111 |
106 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08831078 |
107 | diterpenoid biosynthetic process (GO:0016102) | 3.07537245 |
108 | wound healing, spreading of cells (GO:0044319) | 3.06583763 |
109 | myeloid leukocyte migration (GO:0097529) | 3.05329966 |
110 | adaptation of signaling pathway (GO:0023058) | 3.04491642 |
111 | regulation of sarcomere organization (GO:0060297) | 3.00317614 |
112 | positive regulation of fibroblast migration (GO:0010763) | 2.97372573 |
113 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96072753 |
114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94329488 |
115 | negative regulation of cell killing (GO:0031342) | 2.94329488 |
116 | microglial cell activation (GO:0001774) | 2.92986590 |
117 | positive regulation of chemokine secretion (GO:0090197) | 2.91812042 |
118 | positive regulation of lamellipodium organization (GO:1902745) | 2.91251149 |
119 | chronic inflammatory response (GO:0002544) | 2.89555220 |
120 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89297511 |
121 | leukocyte chemotaxis (GO:0030595) | 2.88550944 |
122 | substrate-dependent cell migration (GO:0006929) | 2.88149354 |
123 | blood vessel maturation (GO:0001955) | 2.87831389 |
124 | regulation of systemic arterial blood pressure (GO:0003073) | 2.84641218 |
125 | negative regulation of fibrinolysis (GO:0051918) | 2.84451983 |
126 | reactive oxygen species biosynthetic process (GO:1903409) | 2.84209824 |
127 | hepatocyte apoptotic process (GO:0097284) | 2.83346949 |
128 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82205440 |
129 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.82166271 |
130 | negative regulation of interleukin-8 production (GO:0032717) | 2.81651268 |
131 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.81092468 |
132 | regulation of endothelial cell migration (GO:0010594) | 2.79714638 |
133 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.78443342 |
134 | regulation of vasculogenesis (GO:2001212) | 2.78257031 |
135 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.74361856 |
136 | negative regulation of fatty acid transport (GO:2000192) | 2.73919408 |
137 | regulation of chemokine secretion (GO:0090196) | 2.73891983 |
138 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73511118 |
139 | phospholipid scrambling (GO:0017121) | 2.73149055 |
140 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73138537 |
141 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73138537 |
142 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73138537 |
143 | modulation by symbiont of host immune response (GO:0052553) | 2.73138537 |
144 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73138537 |
145 | modulation by symbiont of host defense response (GO:0052031) | 2.73138537 |
146 | positive regulation of osteoblast proliferation (GO:0033690) | 2.71848179 |
147 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.71217507 |
148 | establishment of endothelial barrier (GO:0061028) | 2.68854053 |
149 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68743177 |
150 | negative regulation of glial cell proliferation (GO:0060253) | 2.68570749 |
151 | mucosal immune response (GO:0002385) | 2.68548790 |
152 | growth hormone receptor signaling pathway (GO:0060396) | 2.67458637 |
153 | negative regulation of epithelial cell migration (GO:0010633) | 2.67377213 |
154 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.66041214 |
155 | regulation of female receptivity (GO:0045924) | 2.65986011 |
156 | regulation of urine volume (GO:0035809) | 2.65918082 |
157 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.65790332 |
158 | anatomical structure maturation (GO:0071695) | 2.64879248 |
159 | G-protein coupled receptor internalization (GO:0002031) | 2.64205241 |
160 | myeloid cell activation involved in immune response (GO:0002275) | 2.64102590 |
161 | positive regulation of endothelial cell migration (GO:0010595) | 2.63718367 |
162 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63143350 |
163 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62935553 |
164 | regulation of macrophage chemotaxis (GO:0010758) | 2.62062702 |
165 | detection of biotic stimulus (GO:0009595) | 2.61773979 |
166 | response to muramyl dipeptide (GO:0032495) | 2.61717409 |
167 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61240250 |
168 | histamine secretion (GO:0001821) | 2.60734569 |
169 | neuron remodeling (GO:0016322) | 2.59744248 |
170 | actin filament depolymerization (GO:0030042) | 2.54500291 |
171 | necroptotic process (GO:0070266) | 2.52840619 |
172 | organ or tissue specific immune response (GO:0002251) | 2.50405677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.83567942 |
2 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.33719181 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84788913 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49939524 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.45985470 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35496779 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15830614 |
8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.15080586 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.92703758 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85207680 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.81047466 |
12 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.74552684 |
13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64340246 |
14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.54760784 |
15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.50861014 |
16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29086674 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21084650 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20487731 |
19 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.16871036 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15644171 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09609147 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03983418 |
23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93333107 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92584359 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88003881 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81822218 |
27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75437383 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75258480 |
29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74844999 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.74137432 |
31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73981204 |
32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62716406 |
33 | MAF_26560356_Chip-Seq_TH1_Human | 1.61145305 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60603479 |
35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59801645 |
36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52767125 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51599419 |
38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49184153 |
39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45709013 |
40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45527672 |
41 | GATA2_19941826_ChIP-Seq_K562_Human | 1.42190245 |
42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40522060 |
43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36830174 |
44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36453929 |
45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36274439 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.33842810 |
47 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33497472 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33072583 |
49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32471958 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32387036 |
51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31988908 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31125029 |
53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31109084 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30935656 |
55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27774692 |
56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27714505 |
57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27253244 |
58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23012816 |
59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22669930 |
60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21634942 |
61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19394488 |
62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18618473 |
63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17846864 |
64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17650321 |
65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15623311 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14272047 |
67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13076151 |
68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12336539 |
69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11979099 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11648292 |
71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11391230 |
72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10970150 |
73 | MYC_22102868_ChIP-Seq_BL_Human | 1.10504299 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08283144 |
75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08272860 |
76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05307399 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05220587 |
78 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04455684 |
79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04272616 |
80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04130350 |
81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03993306 |
82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03993306 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03934223 |
84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02576587 |
85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02310674 |
86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02303307 |
87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01518361 |
88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98242506 |
89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97641328 |
90 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97031355 |
91 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96740554 |
92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96702764 |
93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96228258 |
94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96129852 |
95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95319664 |
96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95211337 |
97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94749940 |
98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94575235 |
99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93365008 |
100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92513181 |
101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92255789 |
102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91800381 |
103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90798863 |
104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90195294 |
105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89873598 |
106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89873598 |
107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89663339 |
108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89595446 |
109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88921393 |
110 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88905361 |
111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88116255 |
112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88096123 |
113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88020297 |
114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87829062 |
115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83398426 |
116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80587182 |
117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79702275 |
118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79373419 |
119 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78824628 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009278_abnormal_bone_marrow | 5.02766723 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 4.79998326 |
3 | MP0005167_abnormal_blood-brain_barrier | 4.22498271 |
4 | MP0003436_decreased_susceptibility_to | 3.92623724 |
5 | MP0003303_peritoneal_inflammation | 3.54714028 |
6 | MP0003724_increased_susceptibility_to | 3.30755292 |
7 | MP0005397_hematopoietic_system_phenotyp | 2.91571079 |
8 | MP0001545_abnormal_hematopoietic_system | 2.91571079 |
9 | MP0000343_altered_response_to | 2.79578336 |
10 | MP0009785_altered_susceptibility_to | 2.77099400 |
11 | MP0004858_abnormal_nervous_system | 2.67842383 |
12 | MP0002419_abnormal_innate_immunity | 2.60518317 |
13 | MP0003183_abnormal_peptide_metabolism | 2.59161010 |
14 | MP0003828_pulmonary_edema | 2.57271390 |
15 | MP0003279_aneurysm | 2.45763250 |
16 | MP0004883_abnormal_blood_vessel | 2.42588532 |
17 | MP0003075_altered_response_to | 2.32742547 |
18 | MP0001853_heart_inflammation | 2.30264233 |
19 | MP0008004_abnormal_stomach_pH | 2.24388136 |
20 | MP0001533_abnormal_skeleton_physiology | 2.18777908 |
21 | MP0002277_abnormal_respiratory_mucosa | 2.17587614 |
22 | MP0009764_decreased_sensitivity_to | 2.11964950 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.11888822 |
24 | MP0004233_abnormal_muscle_weight | 2.05730782 |
25 | MP0005025_abnormal_response_to | 1.91391134 |
26 | MP0003705_abnormal_hypodermis_morpholog | 1.86432155 |
27 | MP0003300_gastrointestinal_ulcer | 1.84154102 |
28 | MP0004808_abnormal_hematopoietic_stem | 1.81773949 |
29 | MP0005164_abnormal_response_to | 1.80845586 |
30 | MP0002405_respiratory_system_inflammati | 1.76031061 |
31 | MP0003566_abnormal_cell_adhesion | 1.69916418 |
32 | MP0005166_decreased_susceptibility_to | 1.69191245 |
33 | MP0010368_abnormal_lymphatic_system | 1.66218798 |
34 | MP0002396_abnormal_hematopoietic_system | 1.63511999 |
35 | MP0000465_gastrointestinal_hemorrhage | 1.63436502 |
36 | MP0005000_abnormal_immune_tolerance | 1.62077147 |
37 | MP0000858_altered_metastatic_potential | 1.60165997 |
38 | MP0001851_eye_inflammation | 1.53722002 |
39 | MP0005023_abnormal_wound_healing | 1.53210487 |
40 | MP0001819_abnormal_immune_cell | 1.48336697 |
41 | MP0005464_abnormal_platelet_physiology | 1.48288484 |
42 | MP0002933_joint_inflammation | 1.47373158 |
43 | MP0002420_abnormal_adaptive_immunity | 1.46448358 |
44 | MP0001845_abnormal_inflammatory_respons | 1.46061465 |
45 | MP0002452_abnormal_antigen_presenting | 1.41235981 |
46 | MP0003448_altered_tumor_morphology | 1.39899530 |
47 | MP0001958_emphysema | 1.37786758 |
48 | MP0003950_abnormal_plasma_membrane | 1.35478922 |
49 | MP0010155_abnormal_intestine_physiology | 1.31136174 |
50 | MP0004145_abnormal_muscle_electrophysio | 1.30727087 |
51 | MP0002127_abnormal_cardiovascular_syste | 1.30550419 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.30337335 |
53 | MP0004510_myositis | 1.27852814 |
54 | MP0001835_abnormal_antigen_presentation | 1.27147933 |
55 | MP0001800_abnormal_humoral_immune | 1.26042625 |
56 | MP0002132_abnormal_respiratory_system | 1.25839068 |
57 | MP0003045_fibrosis | 1.24506678 |
58 | MP0000685_abnormal_immune_system | 1.24278266 |
59 | MP0002332_abnormal_exercise_endurance | 1.21954637 |
60 | MP0010352_gastrointestinal_tract_polyps | 1.21857993 |
61 | MP0001986_abnormal_taste_sensitivity | 1.20688897 |
62 | MP0001915_intracranial_hemorrhage | 1.17876379 |
63 | MP0002723_abnormal_immune_serum | 1.17751748 |
64 | MP0002877_abnormal_melanocyte_morpholog | 1.16271733 |
65 | MP0001879_abnormal_lymphatic_vessel | 1.16123905 |
66 | MP0002138_abnormal_hepatobiliary_system | 1.14939760 |
67 | MP0001873_stomach_inflammation | 1.14304085 |
68 | MP0005645_abnormal_hypothalamus_physiol | 1.13762023 |
69 | MP0003453_abnormal_keratinocyte_physiol | 1.12929745 |
70 | MP0001790_abnormal_immune_system | 1.10742538 |
71 | MP0005387_immune_system_phenotype | 1.10742538 |
72 | MP0002133_abnormal_respiratory_system | 1.10294795 |
73 | MP0005388_respiratory_system_phenotype | 1.10294795 |
74 | MP0001348_abnormal_lacrimal_gland | 1.07751643 |
75 | MP0003091_abnormal_cell_migration | 1.05447728 |
76 | MP0003638_abnormal_response/metabolism_ | 1.03710785 |
77 | MP0005409_darkened_coat_color | 1.02730973 |
78 | MP0004215_abnormal_myocardial_fiber | 1.02138360 |
79 | MP0004484_altered_response_of | 1.02031892 |
80 | MP0005390_skeleton_phenotype | 1.01936936 |
81 | MP0000249_abnormal_blood_vessel | 1.01179657 |
82 | MP0004084_abnormal_cardiac_muscle | 1.00913935 |
83 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00284096 |
84 | MP0005451_abnormal_body_composition | 0.96210977 |
85 | MP0000716_abnormal_immune_system | 0.95646040 |
86 | MP0000678_abnormal_parathyroid_gland | 0.94531779 |
87 | MP0002972_abnormal_cardiac_muscle | 0.94305902 |
88 | MP0005595_abnormal_vascular_smooth | 0.93853685 |
89 | MP0002398_abnormal_bone_marrow | 0.88887247 |
90 | MP0005076_abnormal_cell_differentiation | 0.88310849 |
91 | MP0008260_abnormal_autophagy | 0.86671650 |
92 | MP0003868_abnormal_feces_composition | 0.86290450 |
93 | MP0008469_abnormal_protein_level | 0.86157084 |
94 | MP0004782_abnormal_surfactant_physiolog | 0.85449222 |
95 | MP0002166_altered_tumor_susceptibility | 0.84101036 |
96 | MP0002168_other_aberrant_phenotype | 0.83018649 |
97 | MP0002925_abnormal_cardiovascular_devel | 0.82341905 |
98 | MP0002128_abnormal_blood_circulation | 0.81973256 |
99 | MP0006082_CNS_inflammation | 0.81377041 |
100 | MP0002429_abnormal_blood_cell | 0.81076884 |
101 | MP0010234_abnormal_vibrissa_follicle | 0.79976852 |
102 | MP0005385_cardiovascular_system_phenoty | 0.79357374 |
103 | MP0001544_abnormal_cardiovascular_syste | 0.79357374 |
104 | MP0010630_abnormal_cardiac_muscle | 0.76127387 |
105 | MP0001346_abnormal_lacrimal_gland | 0.75405202 |
106 | MP0005165_increased_susceptibility_to | 0.75242235 |
107 | MP0000767_abnormal_smooth_muscle | 0.75167635 |
108 | MP0009763_increased_sensitivity_to | 0.73337119 |
109 | MP0002295_abnormal_pulmonary_circulatio | 0.73265680 |
110 | MP0004947_skin_inflammation | 0.72893298 |
111 | MP0004272_abnormal_basement_membrane | 0.72779441 |
112 | MP0001663_abnormal_digestive_system | 0.68959280 |
113 | MP0005310_abnormal_salivary_gland | 0.68926154 |
114 | MP0000689_abnormal_spleen_morphology | 0.68861429 |
115 | MP0006138_congestive_heart_failure | 0.68082529 |
116 | MP0006276_abnormal_autonomic_nervous | 0.67996395 |
117 | MP0006054_spinal_hemorrhage | 0.67123244 |
118 | MP0005671_abnormal_response_to | 0.67059395 |
119 | MP0003172_abnormal_lysosome_physiology | 0.66828560 |
120 | MP0001614_abnormal_blood_vessel | 0.66717772 |
121 | MP0002722_abnormal_immune_system | 0.65502029 |
122 | MP0002282_abnormal_trachea_morphology | 0.64933604 |
123 | MP0004036_abnormal_muscle_relaxation | 0.64620413 |
124 | MP0001849_ear_inflammation | 0.64097726 |
125 | MP0005360_urolithiasis | 0.63576075 |
126 | MP0008961_abnormal_basal_metabolism | 0.63016251 |
127 | MP0005084_abnormal_gallbladder_morpholo | 0.61463195 |
128 | MP0001175_abnormal_lung_morphology | 0.61298506 |
129 | MP0000516_abnormal_urinary_system | 0.60578801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 8.00283273 |
2 | Recurrent abscess formation (HP:0002722) | 7.72302048 |
3 | Spontaneous hematomas (HP:0007420) | 7.16968896 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.10925967 |
5 | Recurrent bacterial skin infections (HP:0005406) | 6.22823553 |
6 | Obstructive lung disease (HP:0006536) | 5.13397230 |
7 | Chronic obstructive pulmonary disease (HP:0006510) | 5.13397230 |
8 | Abnormality of macrophages (HP:0004311) | 4.54134695 |
9 | Hematochezia (HP:0002573) | 4.33917043 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 4.33621311 |
11 | Gingivitis (HP:0000230) | 4.18439953 |
12 | Myositis (HP:0100614) | 4.17373903 |
13 | Menorrhagia (HP:0000132) | 4.12373021 |
14 | Abnormal platelet function (HP:0011869) | 3.88112674 |
15 | Impaired platelet aggregation (HP:0003540) | 3.88112674 |
16 | Urticaria (HP:0001025) | 3.83003736 |
17 | Recurrent skin infections (HP:0001581) | 3.69025680 |
18 | Recurrent fungal infections (HP:0002841) | 3.54658662 |
19 | Stomatitis (HP:0010280) | 3.37600559 |
20 | Cellulitis (HP:0100658) | 3.29819005 |
21 | Abnormality of the nasal mucosa (HP:0000433) | 3.23977320 |
22 | Pigmentary retinal degeneration (HP:0001146) | 3.16848257 |
23 | Skull defect (HP:0001362) | 3.11305771 |
24 | Esophageal varix (HP:0002040) | 3.10780392 |
25 | Orchitis (HP:0100796) | 3.07965593 |
26 | Ventricular tachycardia (HP:0004756) | 3.04518986 |
27 | Papilledema (HP:0001085) | 3.04237520 |
28 | Abnormality of the hepatic vasculature (HP:0006707) | 2.99961671 |
29 | Interstitial pulmonary disease (HP:0006530) | 2.96879386 |
30 | Abnormal vertebral ossification (HP:0100569) | 2.86954512 |
31 | Metaphyseal irregularity (HP:0003025) | 2.86638569 |
32 | Muscle fiber splitting (HP:0003555) | 2.85414042 |
33 | Thickened calvaria (HP:0002684) | 2.84639269 |
34 | Difficulty running (HP:0009046) | 2.84473808 |
35 | Short femoral neck (HP:0100864) | 2.80362169 |
36 | Meningitis (HP:0001287) | 2.78369608 |
37 | Right ventricular cardiomyopathy (HP:0011663) | 2.75075849 |
38 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.72656098 |
39 | Polycythemia (HP:0001901) | 2.72277673 |
40 | Pulmonary embolism (HP:0002204) | 2.67500760 |
41 | Stenosis of the external auditory canal (HP:0000402) | 2.66966923 |
42 | Wrist flexion contracture (HP:0001239) | 2.64419008 |
43 | Protrusio acetabuli (HP:0003179) | 2.62875874 |
44 | Abnormal platelet volume (HP:0011876) | 2.59915007 |
45 | Spondylolisthesis (HP:0003302) | 2.56587748 |
46 | Increased connective tissue (HP:0009025) | 2.55635221 |
47 | Hypertensive crisis (HP:0100735) | 2.53195666 |
48 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.51768661 |
49 | Adactyly (HP:0009776) | 2.51130456 |
50 | Epistaxis (HP:0000421) | 2.45648647 |
51 | Subcapsular cataract (HP:0000523) | 2.40052629 |
52 | Hepatosplenomegaly (HP:0001433) | 2.39292391 |
53 | Hyporeflexia of lower limbs (HP:0002600) | 2.35637224 |
54 | Lymphangioma (HP:0100764) | 2.35308290 |
55 | Periodontitis (HP:0000704) | 2.34553855 |
56 | Chest pain (HP:0100749) | 2.34168536 |
57 | Difficulty climbing stairs (HP:0003551) | 2.33341721 |
58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31777392 |
59 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.27753246 |
60 | Keratoconjunctivitis (HP:0001096) | 2.27604418 |
61 | Prolonged bleeding time (HP:0003010) | 2.26849354 |
62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26578293 |
63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26578293 |
64 | Hemoptysis (HP:0002105) | 2.25443121 |
65 | Autoimmune thrombocytopenia (HP:0001973) | 2.24278098 |
66 | Asymmetry of the thorax (HP:0001555) | 2.24113225 |
67 | Vacuolated lymphocytes (HP:0001922) | 2.23649386 |
68 | Hypochromic microcytic anemia (HP:0004840) | 2.19945181 |
69 | Overgrowth (HP:0001548) | 2.17088510 |
70 | Hemorrhage of the eye (HP:0011885) | 2.16753382 |
71 | Skin ulcer (HP:0200042) | 2.16611411 |
72 | Absent hand (HP:0004050) | 2.16082813 |
73 | Thrombophlebitis (HP:0004418) | 2.14845187 |
74 | Pustule (HP:0200039) | 2.12467436 |
75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.11568302 |
76 | Pulmonary hypertension (HP:0002092) | 2.10938045 |
77 | Keratitis (HP:0000491) | 2.10937187 |
78 | Abnormal foot bone ossification (HP:0010675) | 2.10394605 |
79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.09696642 |
80 | Cerebral aneurysm (HP:0004944) | 2.09125977 |
81 | Increased mean platelet volume (HP:0011877) | 2.08873444 |
82 | Osteomyelitis (HP:0002754) | 2.08390606 |
83 | Peritonitis (HP:0002586) | 2.07733106 |
84 | Gingival bleeding (HP:0000225) | 2.07667981 |
85 | Inflammation of the large intestine (HP:0002037) | 2.07065211 |
86 | Mucosal telangiectasiae (HP:0100579) | 2.05354980 |
87 | Broad face (HP:0000283) | 2.05073205 |
88 | Arterial tortuosity (HP:0005116) | 2.04788817 |
89 | Mitral valve prolapse (HP:0001634) | 2.03680139 |
90 | Abnormality of the peritoneum (HP:0002585) | 2.02539434 |
91 | Sepsis (HP:0100806) | 2.01912184 |
92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01408118 |
93 | Keratoconjunctivitis sicca (HP:0001097) | 2.01117034 |
94 | Chronic otitis media (HP:0000389) | 1.99344329 |
95 | Gastrointestinal infarctions (HP:0005244) | 1.99198674 |
96 | Weak cry (HP:0001612) | 1.97897693 |
97 | Visceral angiomatosis (HP:0100761) | 1.97287981 |
98 | IgM deficiency (HP:0002850) | 1.96352798 |
99 | Vascular tortuosity (HP:0004948) | 1.94696758 |
100 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.92910677 |
101 | Arterial thrombosis (HP:0004420) | 1.92891967 |
102 | Increased variability in muscle fiber diameter (HP:0003557) | 1.92830373 |
103 | Orthostatic hypotension (HP:0001278) | 1.91499887 |
104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90484019 |
105 | Gastrointestinal inflammation (HP:0004386) | 1.90227437 |
106 | Amyloidosis (HP:0011034) | 1.89826632 |
107 | Conjunctival telangiectasia (HP:0000524) | 1.88856489 |
108 | Exercise-induced muscle cramps (HP:0003710) | 1.88365170 |
109 | Teleangiectasia of the skin (HP:0100585) | 1.87977031 |
110 | Vertigo (HP:0002321) | 1.87396362 |
111 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87139677 |
112 | Recurrent corneal erosions (HP:0000495) | 1.87013737 |
113 | Aortic valve stenosis (HP:0001650) | 1.86750241 |
114 | Cheilitis (HP:0100825) | 1.85731394 |
115 | Joint hemorrhage (HP:0005261) | 1.85590739 |
116 | Hemangiomatosis (HP:0007461) | 1.85500250 |
117 | Hypochromic anemia (HP:0001931) | 1.83675423 |
118 | Porencephaly (HP:0002132) | 1.82160814 |
119 | Petechiae (HP:0000967) | 1.82074608 |
120 | Male infertility (HP:0003251) | 1.81234476 |
121 | Increased IgE level (HP:0003212) | 1.80597039 |
122 | Aortic aneurysm (HP:0004942) | 1.80277787 |
123 | Venous insufficiency (HP:0005293) | 1.79703913 |
124 | Recurrent pneumonia (HP:0006532) | 1.78944940 |
125 | Stroke (HP:0001297) | 1.78215228 |
126 | Nonimmune hydrops fetalis (HP:0001790) | 1.77565979 |
127 | Vertebral clefting (HP:0008428) | 1.76634890 |
128 | Subacute progressive viral hepatitis (HP:0006572) | 1.76422868 |
129 | Vasculitis (HP:0002633) | 1.75697253 |
130 | Portal hypertension (HP:0001409) | 1.73033371 |
131 | Tinnitus (HP:0000360) | 1.72772940 |
132 | Episodic fever (HP:0001954) | 1.72753018 |
133 | Cerebral hemorrhage (HP:0001342) | 1.72029844 |
134 | Retrobulbar optic neuritis (HP:0100654) | 1.71348508 |
135 | Optic neuritis (HP:0100653) | 1.71348508 |
136 | Microcytic anemia (HP:0001935) | 1.69826017 |
137 | Neonatal death (HP:0003811) | 1.69282779 |
138 | Nasal polyposis (HP:0100582) | 1.69027612 |
139 | Long clavicles (HP:0000890) | 1.67939300 |
140 | Thoracic kyphosis (HP:0002942) | 1.67117700 |
141 | High pitched voice (HP:0001620) | 1.63745656 |
142 | Abnormality of the endocardium (HP:0004306) | 1.62031806 |
143 | Leukocytosis (HP:0001974) | 1.61965738 |
144 | Lipoatrophy (HP:0100578) | 1.61740879 |
145 | Cavernous hemangioma (HP:0001048) | 1.60525662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP2K3 | 3.52236426 |
2 | STK10 | 3.50792631 |
3 | EPHB1 | 3.45792584 |
4 | TRPM7 | 3.36137180 |
5 | IRAK4 | 3.18668582 |
6 | TGFBR2 | 3.09953771 |
7 | ERBB3 | 2.98433037 |
8 | CSK | 2.85762109 |
9 | BLK | 2.65551516 |
10 | ERN1 | 2.60634729 |
11 | TIE1 | 2.53539347 |
12 | FER | 2.11323886 |
13 | FGR | 2.07242295 |
14 | KDR | 2.05605864 |
15 | MAP3K3 | 2.01313768 |
16 | MAP3K12 | 1.96917184 |
17 | TAOK1 | 1.87858332 |
18 | RIPK1 | 1.83722439 |
19 | DMPK | 1.76340964 |
20 | KSR2 | 1.76240303 |
21 | LRRK2 | 1.75413874 |
22 | CLK1 | 1.75011054 |
23 | HCK | 1.70119156 |
24 | EPHB2 | 1.66636121 |
25 | MAP3K6 | 1.62001250 |
26 | MYLK | 1.60206086 |
27 | DAPK2 | 1.54027353 |
28 | FES | 1.53916257 |
29 | PTK6 | 1.47115259 |
30 | JAK3 | 1.46568992 |
31 | MOS | 1.45752146 |
32 | STK24 | 1.45448629 |
33 | RIPK4 | 1.42919265 |
34 | TRIB3 | 1.41559229 |
35 | PAK4 | 1.36326590 |
36 | TGFBR1 | 1.30735572 |
37 | ZAP70 | 1.30580848 |
38 | GRK7 | 1.22423005 |
39 | PRKG2 | 1.19344453 |
40 | GRK6 | 1.18981639 |
41 | * BTK | 1.18098892 |
42 | PTK2B | 1.15530897 |
43 | TTN | 1.11676854 |
44 | TESK1 | 1.06288046 |
45 | MAPKAPK2 | 1.04640926 |
46 | IRAK1 | 1.01281382 |
47 | MAP3K11 | 1.00425282 |
48 | PKN2 | 0.98888306 |
49 | RAF1 | 0.95636150 |
50 | IRAK3 | 0.94995176 |
51 | FRK | 0.93694509 |
52 | TYK2 | 0.92359716 |
53 | RPS6KA4 | 0.90478223 |
54 | MAP3K9 | 0.86747216 |
55 | JAK2 | 0.81184537 |
56 | YES1 | 0.81050672 |
57 | SGK3 | 0.80669999 |
58 | GRK5 | 0.80146297 |
59 | SGK2 | 0.79600335 |
60 | TNK2 | 0.79027259 |
61 | MAP2K6 | 0.78535283 |
62 | MARK2 | 0.74880886 |
63 | PIK3CG | 0.74609483 |
64 | TBK1 | 0.73671961 |
65 | TAOK3 | 0.73278289 |
66 | PRKD3 | 0.69167450 |
67 | IRAK2 | 0.68544200 |
68 | MAPKAPK5 | 0.67783918 |
69 | LIMK1 | 0.67652162 |
70 | MAPKAPK3 | 0.67500524 |
71 | * TEC | 0.66621151 |
72 | RPS6KB2 | 0.64341831 |
73 | MATK | 0.64053299 |
74 | CDK9 | 0.63426124 |
75 | MAP3K1 | 0.59462668 |
76 | RPS6KA2 | 0.58753921 |
77 | MAPK15 | 0.58255636 |
78 | RPS6KC1 | 0.55301331 |
79 | RPS6KL1 | 0.55301331 |
80 | GRK1 | 0.54892176 |
81 | RPS6KA6 | 0.54628161 |
82 | MAP3K14 | 0.54329068 |
83 | JAK1 | 0.54277049 |
84 | MAP4K1 | 0.53263416 |
85 | MAP3K2 | 0.52284294 |
86 | FGFR4 | 0.51214748 |
87 | FYN | 0.50776198 |
88 | IKBKE | 0.50048280 |
89 | EIF2AK2 | 0.49668892 |
90 | MAP3K8 | 0.49238256 |
91 | MAPK12 | 0.45982045 |
92 | FGFR2 | 0.45627326 |
93 | SMG1 | 0.45157800 |
94 | PRKD1 | 0.44004414 |
95 | EGFR | 0.42862292 |
96 | FGFR3 | 0.41152334 |
97 | PDPK1 | 0.40658028 |
98 | RET | 0.40655339 |
99 | PRKD2 | 0.38037692 |
100 | MAP2K1 | 0.38008606 |
101 | ACVR1B | 0.37834309 |
102 | BMPR2 | 0.37584961 |
103 | NTRK1 | 0.37165955 |
104 | LYN | 0.36814971 |
105 | PRKCD | 0.36699573 |
106 | MAPK4 | 0.36677293 |
107 | PRKCQ | 0.36501814 |
108 | NEK9 | 0.35188323 |
109 | EPHA3 | 0.35062295 |
110 | PRKAA2 | 0.34814034 |
111 | SGK494 | 0.34663797 |
112 | SGK223 | 0.34663797 |
113 | ABL1 | 0.34375234 |
114 | MAP3K5 | 0.33783124 |
115 | STK3 | 0.33582483 |
116 | * ITK | 0.33409274 |
117 | TESK2 | 0.31528873 |
118 | PRKCH | 0.31466332 |
119 | MKNK1 | 0.30843558 |
120 | * PTK2 | 0.30597878 |
121 | MAP3K7 | 0.29728128 |
122 | SYK | 0.28548821 |
123 | MAPK11 | 0.27913041 |
124 | PDGFRB | 0.27632567 |
125 | PDK1 | 0.26553404 |
126 | EEF2K | 0.26458464 |
127 | CDC42BPA | 0.26215171 |
128 | NLK | 0.26178380 |
129 | ALK | 0.25971127 |
130 | ROCK1 | 0.25960028 |
131 | STK11 | 0.25919681 |
132 | KSR1 | 0.25699624 |
133 | CDK8 | 0.25375411 |
134 | LCK | 0.24958208 |
135 | ROCK2 | 0.24902360 |
136 | PAK6 | 0.24452563 |
137 | MAP2K4 | 0.24296726 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.46670271 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.34627626 |
3 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 3.27067935 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.29119933 |
5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.20829358 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11133035 |
7 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.00471279 |
8 | Taste transduction_Homo sapiens_hsa04742 | 1.93531034 |
9 | Bladder cancer_Homo sapiens_hsa05219 | 1.93285792 |
10 | Shigellosis_Homo sapiens_hsa05131 | 1.85137398 |
11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.67724130 |
12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65183999 |
13 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62537031 |
14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62048188 |
15 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.61015658 |
16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53520419 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.50387405 |
18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50343410 |
19 | Adherens junction_Homo sapiens_hsa04520 | 1.48126942 |
20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48038407 |
21 | Salmonella infection_Homo sapiens_hsa05132 | 1.47556086 |
22 | Platelet activation_Homo sapiens_hsa04611 | 1.45343582 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44561957 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.42202999 |
25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.41859704 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41497704 |
27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38911858 |
28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33114016 |
29 | Amoebiasis_Homo sapiens_hsa05146 | 1.28491741 |
30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28390946 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26732763 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.23137138 |
33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.18807958 |
34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16765228 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15749851 |
36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13139729 |
37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12983002 |
38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12422442 |
39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10770813 |
40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10121873 |
41 | Legionellosis_Homo sapiens_hsa05134 | 1.09484716 |
42 | Focal adhesion_Homo sapiens_hsa04510 | 1.09045262 |
43 | Insulin resistance_Homo sapiens_hsa04931 | 1.06950847 |
44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06674054 |
45 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04679626 |
46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02561919 |
47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01568108 |
48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00595996 |
49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00396521 |
50 | Malaria_Homo sapiens_hsa05144 | 0.97111898 |
51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96950016 |
52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96923346 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96589477 |
54 | Influenza A_Homo sapiens_hsa05164 | 0.94884505 |
55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92669876 |
56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92502195 |
57 | Phagosome_Homo sapiens_hsa04145 | 0.91593518 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89794893 |
59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89669731 |
60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85909033 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83118825 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82751622 |
63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81479557 |
64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81224918 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79672225 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.79420048 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78774571 |
68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78640538 |
69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78568728 |
70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78515914 |
71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77839285 |
72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76810081 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.76434465 |
74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75443614 |
75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73705081 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72057635 |
77 | Endocytosis_Homo sapiens_hsa04144 | 0.71763759 |
78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70440638 |
79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70439157 |
80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70273322 |
81 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70171828 |
82 | Measles_Homo sapiens_hsa05162 | 0.69874165 |
83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69654879 |
84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68522574 |
85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66847812 |
86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65732581 |
87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64134966 |
88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63889485 |
89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63120913 |
90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62154204 |
91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60027216 |
92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58909654 |
93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58374588 |
94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56414985 |
95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56229178 |
96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55733019 |
97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54667122 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53477289 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53384881 |
100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52402534 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51437816 |
102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50012313 |
103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49983707 |
104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49254368 |
105 | Asthma_Homo sapiens_hsa05310 | 0.47098580 |
106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47005675 |
107 | Prostate cancer_Homo sapiens_hsa05215 | 0.46703588 |
108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46589616 |
109 | Axon guidance_Homo sapiens_hsa04360 | 0.46373380 |
110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44758620 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44649368 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.44131043 |
113 | Long-term depression_Homo sapiens_hsa04730 | 0.42552466 |
114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42508870 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42287133 |
116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41666104 |
117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41376736 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40455082 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37661972 |
120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36239711 |
121 | Glioma_Homo sapiens_hsa05214 | 0.35854812 |